Detalhe da pesquisa
1.
USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K.
Mol Oncol
; 16(17): 3082-3106, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35364627